Value of Serum Asymmetric Dimethylarginine (ADMA) As a Novel Biomarker for Uveitis in Behçet's Disease.
Omima Ahmed SayedRasha Ali Abdel-MagiedMostafa Ahmed Abu ElelaAbdallah Mm SafwatAhmed M Abdel-NasserPublished in: Ocular immunology and inflammation (2024)
Serum ADMA level can serve as a novel biomarker of uveitis in BD and its severity with good diagnostic accuracy, regardless of its site or activity.